Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that intravenous regadenoson is equivalent to
intravenous Adenoscan® for the physiological assessment of intermediate coronary lesions.